Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2025 Filed Apr 3, 2025 20:31 UTC |
Aslam ShakilChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001415889-25-009965 · form4-04032025_080416.xml · derivative · entry 2 Aslam Shakil · CIK 0002040805 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2035-04-01 F2 · derivative.exercise_date: On April 2, 2025, the reporting person was granted an option to purchase 80,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 20:31 UTC |
Aslam ShakilChief Medical Officer
|
GrantCommom Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-009965 · form4-04032025_080416.xml · nonDerivative · entry 1 Aslam Shakil · CIK 0002040805 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,695 F1 · shares: The restricted stock units shall vest in three equal consecutive annual installments on April 2, 2026, April 2, 2027 and April 2, 2028. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 20:29 UTC |
ASADORIAN RAFFIChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001415889-25-009948 · form4-04032025_080413.xml · derivative · entry 2 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2035-04-01 F2 · derivative.exercise_date: On April 2, 2025, the reporting person was granted an option to purchase 80,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 20:29 UTC |
ASADORIAN RAFFIChief Financial Officer
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-009948 · form4-04032025_080413.xml · nonDerivative · entry 1 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,214 F1 · shares: The restricted stock units shall vest in three equal consecutive annual installments on April 2, 2026, April 2, 2027 and April 2, 2028. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 20:30 UTC |
Dasu Badri NChief Engineering Officer
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001415889-25-009953 · form4-04032025_080409.xml · derivative · entry 2 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2035-04-01 F2 · derivative.exercise_date: On April 2, 2025, the reporting person was granted an option to purchase 80,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 20:30 UTC |
Dasu Badri NChief Engineering Officer
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-009953 · form4-04032025_080409.xml · nonDerivative · entry 1 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,011 F1 · shares: The restricted stock units shall vest in three equal consecutive annual installments on April 2, 2026, April 2, 2027 and April 2, 2028. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 20:28 UTC |
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 365,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001415889-25-009947 · form4-04032025_080419.xml · derivative · entry 3 Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,000 Underlying: Common Stock · 365,000 shares Expires 2035-04-01 F3 · derivative.exercise_date: On April 2, 2025, the reporting person was granted an option to purchase 365,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 20:28 UTC |
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 61,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-009947 · form4-04032025_080419.xml · nonDerivative · entry 2 Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 474,769 F1 · shares: The restricted stock units shall vest in three equal consecutive annual installments on April 2, 2026, April 2, 2027 and April 2, 2028. F2 · balance_after: Balance includes non-reportable acquisition of 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 20:28 UTC |
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 213,310 | $0.59 | $124,999.66 |
DisclosureSEC source: 0001415889-25-009947 · form4-04032025_080419.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 403,769 Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 19:21 UTC |
Nantahala Capital Management, LLC10% owner · See remarks
Harkey Wilmot B.10% owner · See remarks
Mack Daniel10% owner · See remarks
|
GrantPre-Funded Warrants · Derivative | 4,266,211 | $0.59 Strike: $0.00 | $2,495,733.44 |
DisclosureSEC source: 0001104659-25-031315 · tm2511376-1_4seq1.xml · derivative · entry 1 Nantahala Capital Management, LLC · CIK 0001472322 · 10% owner · See remarks Harkey Wilmot B. · CIK 0001775952 · 10% owner · See remarks Mack Daniel · CIK 0001775831 · 10% owner · See remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 11,510,601 Underlying: Common Stock · 4,266,211 shares Expires not disclosed F1 · derivative.expiration_date: These Warrants (as defined below) are exercisable indefinitely. F2 · ownership.nature: NCM, an investment adviser to certain private funds and managed accounts (the "NCM Investors") that hold shares of Common Stock and certain derivative securities related thereto (the "Derivatives"), including the warrants to purchase Common Stock disclosed in this Form 4 ("Warrants"), may be deemed a beneficial owner of such Warrants. Each of Mr. Wilmot B. Harkey and Mr. Daniel Mack may be deemed a beneficial owner of the Warrants beneficially owned by NCM. Each of NCM, Mr. Harkey and Mr. Mack (the "Reporting Persons") disclaims beneficial ownership of the Warrants disclosed herein except to the extent of their respective pecuniary interests therein. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:50 UTC |
Dasu Badri NChief Engineering Officer
|
Tax withholdingCommon Stock | 2,644 | $0.67 | $1,771.48 |
DisclosureSEC source: 0001415889-25-004443 · form4-02182025_090249.xml · nonDerivative · entry 1 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,011 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:49 UTC |
ASADORIAN RAFFIChief Financial Officer
|
Tax withholdingCommon Stock | 3,245 | $0.67 | $2,174.15 |
DisclosureSEC source: 0001415889-25-004442 · form4-02182025_090200.xml · nonDerivative · entry 1 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,214 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:47 UTC |
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 10,575 | $0.67 | $7,085.25 |
DisclosureSEC source: 0001415889-25-004440 · form4-02182025_090228.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,459 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| February 11, 2025 Filed Feb 12, 2025 21:11 UTC |
Dasu Badri NChief Engineering Officer
|
Tax withholdingCommon stock | 880 | $0.62 | $545.60 |
DisclosureSEC source: 0001415889-25-003724 · form4-02122025_090208.xml · nonDerivative · entry 2 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,655 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| February 11, 2025 Filed Feb 12, 2025 21:10 UTC |
ASADORIAN RAFFIChief Financial Officer
|
Tax withholdingCommon Stock | 1,060 | $0.62 | $657.20 |
DisclosureSEC source: 0001415889-25-003722 · form4-02122025_090221.xml · nonDerivative · entry 2 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,459 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| February 11, 2025 Filed Feb 12, 2025 21:09 UTC |
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 3,517 | $0.62 | $2,180.54 |
DisclosureSEC source: 0001415889-25-003721 · form4-02122025_090227.xml · nonDerivative · entry 2 Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,034 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:11 UTC |
Dasu Badri NChief Engineering Officer
|
Tax withholdingCommon Stock | 879 | $0.63 | $553.68 |
DisclosureSEC source: 0001415889-25-003724 · form4-02122025_090208.xml · nonDerivative · entry 1 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,535 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:10 UTC |
ASADORIAN RAFFIChief Financial Officer
|
Tax withholdingCommon Stock | 1,059 | $0.63 | $667.06 |
DisclosureSEC source: 0001415889-25-003722 · form4-02122025_090221.xml · nonDerivative · entry 1 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,519 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:09 UTC |
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 3,515 | $0.63 | $2,214.10 |
DisclosureSEC source: 0001415889-25-003721 · form4-02122025_090227.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,551 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| December 05, 2024 Filed Dec 6, 2024 11:05 UTC |
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 5,000 | $0.64 | $3,199.50 |
DisclosureSEC source: 0001415889-24-028440 · form4-12062024_061201.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,066 Read SEC document |
| December 02, 2024 Filed Dec 2, 2024 21:22 UTC |
ASADORIAN RAFFIChief Financial Officer
|
SaleCommon Stock | 155 | $0.77 | $118.89 |
DisclosureSEC source: 0001415889-24-027990 · form4-12022024_091252.xml · nonDerivative · entry 1 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,578 F1 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $0.767 to $0.7671 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:20 UTC |
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 5,000 | $0.73 | $3,649.50 |
DisclosureSEC source: 0001415889-24-027989 · form4-12022024_091204.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,066 Read SEC document |
| August 30, 2024 Filed Sep 3, 2024 20:22 UTC |
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 7,260 | $1.05 | $7,598.32 |
DisclosureSEC source: 0001415889-24-022690 · form4-09032024_080952.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,066 F1 · price: The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $1.035 to $1.05 per share on August 30, 2024. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price. F2 · balance_after: Balance includes non-reportable acquisition of 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 23:14 UTC |
Bozilenko MarinaDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,044 | $0.00 Strike: $0.89 | $0.00 |
DisclosureSEC source: 0001415889-24-018076 · form4-06242024_110623.xml · derivative · entry 2 Bozilenko Marina · CIK 0001853794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,044 Underlying: Common Stock · 13,044 shares Expires 2034-06-23 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 23:14 UTC |
Bozilenko MarinaDirector
|
GrantCommon Stock | 2,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-018076 · form4-06242024_110623.xml · nonDerivative · entry 1 Bozilenko Marina · CIK 0001853794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,780 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 23:13 UTC |
HOFFMAN STEPHEN JDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,044 | $0.00 Strike: $0.89 | $0.00 |
DisclosureSEC source: 0001415889-24-018075 · form4-06242024_110610.xml · derivative · entry 2 HOFFMAN STEPHEN J · CIK 0001190418 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,044 Underlying: Common Stock · 13,044 shares Expires 2034-06-23 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 23:13 UTC |
HOFFMAN STEPHEN JDirector
|
GrantCommon Stock | 2,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-018075 · form4-06242024_110610.xml · nonDerivative · entry 1 HOFFMAN STEPHEN J · CIK 0001190418 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,592 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 23:12 UTC |
ADAMS ADRIANDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,044 | $0.00 Strike: $0.89 | $0.00 |
DisclosureSEC source: 0001415889-24-018074 · form4-06242024_110605.xml · derivative · entry 2 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,044 Underlying: Common Stock · 13,044 shares Expires 2034-06-23 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 23:12 UTC |
ADAMS ADRIANDirector
|
GrantCommon Stock | 2,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-018074 · form4-06242024_110605.xml · nonDerivative · entry 1 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,342 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 23:11 UTC |
Broadfoot Jill MarieDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,044 | $0.00 Strike: $0.89 | $0.00 |
DisclosureSEC source: 0001415889-24-018073 · form4-06242024_110610.xml · derivative · entry 2 Broadfoot Jill Marie · CIK 0001305178 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,044 Underlying: Common Stock · 13,044 shares Expires 2034-06-23 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 23:11 UTC |
Broadfoot Jill MarieDirector
|
GrantCommon Stock | 2,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-018073 · form4-06242024_110610.xml · nonDerivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,280 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 23:10 UTC |
JAIN ABHINAVDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,044 | $0.00 Strike: $0.89 | $0.00 |
DisclosureSEC source: 0001415889-24-018072 · form4-06242024_110607.xml · derivative · entry 2 JAIN ABHINAV · CIK 0001981291 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,044 Underlying: Common Stock · 13,044 shares Expires 2034-06-23 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 23:10 UTC |
JAIN ABHINAVDirector
|
GrantCommon Stock | 2,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-018072 · form4-06242024_110607.xml · nonDerivative · entry 1 JAIN ABHINAV · CIK 0001981291 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,045 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 23:08 UTC |
WAN MARK ADirector
|
GrantStock Option (Right to Buy) · Derivative | 13,044 | $0.00 Strike: $0.89 | $0.00 |
DisclosureSEC source: 0001415889-24-018071 · form4-06242024_110643.xml · derivative · entry 2 WAN MARK A · CIK 0001190472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,044 Underlying: Common Stock · 13,044 shares Expires 2034-06-23 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Company. Read SEC document |
| June 24, 2024 Filed Jun 24, 2024 23:08 UTC |
WAN MARK ADirector
|
GrantCommon Stock | 2,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-018071 · form4-06242024_110643.xml · nonDerivative · entry 1 WAN MARK A · CIK 0001190472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,592 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 14, 2024 Filed Jun 14, 2024 21:19 UTC |
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 1,304 | $1.08 | $1,404.41 |
DisclosureSEC source: 0001415889-24-016974 · form4-06142024_090622.xml · nonDerivative · entry 3 Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,806 Read SEC document |
| June 14, 2024 Filed Feb 26, 2025 23:52 UTC |
Aslam ShakilChief Medical Officer
|
PurchaseCommon Stock | 5,000 | $1.07 | $5,357.00 |
DisclosureSEC source: 0001415889-25-005730 · form4-02262025_110201.xml · nonDerivative · entry 2 Aslam Shakil · CIK 0002040805 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,695 F1 · shares: Price reported is a weighted-average sales price. The shares were purchased at prices ranging from $1.07 to $1.08. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 21:19 UTC |
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 4,570 | $0.97 | $4,438.38 |
DisclosureSEC source: 0001415889-24-016974 · form4-06142024_090622.xml · nonDerivative · entry 2 Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,502 F2 · price: The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.957 to $0.9799 per share on June 13, 2024. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 13, 2024 Filed Feb 26, 2025 23:52 UTC |
Aslam ShakilChief Medical Officer
|
PurchaseCommon Stock | 695 | $0.98 | $681.10 |
DisclosureSEC source: 0001415889-25-005730 · form4-02262025_110201.xml · nonDerivative · entry 1 Aslam Shakil · CIK 0002040805 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,695 Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 21:19 UTC |
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 4,126 | $0.97 | $4,013.36 |
DisclosureSEC source: 0001415889-24-016974 · form4-06142024_090622.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,932 F1 · price: The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.943 to $0.98 per share on June 12, 2024. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 16:30 UTC |
Nantahala Capital Management, LLC10% owner · See remarks
Harkey Wilmot B.10% owner · See remarks
Mack Daniel10% owner · See remarks
|
Other2024 Pre-Funded Warrants · Derivative | 324,675 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001104659-24-037346 · tm249500-1_4seq1.xml · derivative · entry 1 Nantahala Capital Management, LLC · CIK 0001472322 · 10% owner · See remarks Harkey Wilmot B. · CIK 0001775952 · 10% owner · See remarks Mack Daniel · CIK 0001775831 · 10% owner · See remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,493,507 Underlying: Common Stock · 324,675 shares Expires not disclosed F1 · kind: On March 19, 2024, Nantahala Capital Management, LLC ("NCM") entered into a sub-advisory agreement with a client regarding its managed account, pursuant to which NCM acquired voting and investment power over certain securities owned by the client, including Warrants (as defined below) to purchase 324,675 shares of Common Stock at an exercise price of $0.001 per share, subject to a contractual prohibition on any exercise if the Reporting Persons (as defined below) or certain related persons would then beneficially own more than 9.99% of the number of shares of Common Stock outstanding. F1 · price: On March 19, 2024, Nantahala Capital Management, LLC ("NCM") entered into a sub-advisory agreement with a client regarding its managed account, pursuant to which NCM acquired voting and investment power over certain securities owned by the client, including Warrants (as defined below) to purchase 324,675 shares of Common Stock at an exercise price of $0.001 per share, subject to a contractual prohibition on any exercise if the Reporting Persons (as defined below) or certain related persons would then beneficially own more than 9.99% of the number of shares of Common Stock outstanding. F2 · derivative.expiration_date: These Warrants (as defined below) are exercisable indefinitely. F3 · ownership.nature: NCM, an investment adviser to certain private funds and managed accounts (the "NCM Investors") that hold shares of Common Stock and certain derivative securities related thereto (the "Derivatives"), including the warrants to purchase Common Stock disclosed in this Form 4 ("Warrants"), may be deemed a beneficial owner of such Warrants. Each of Mr. Wilmot B. Harkey and Mr. Daniel Mack may be deemed a beneficial owner of the Warrants beneficially owned by NCM. Each of NCM, Mr. Harkey and Mr. Mack (the "Reporting Persons") disclaims beneficial ownership of the Warrants disclosed herein except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 16:01 UTC |
Nantahala Capital Management, LLC10% owner · See remarks
Harkey Wilmot B.10% owner · See remarks
Mack Daniel10% owner · See remarks
|
OtherPut Option (obligation to buy) · Derivative | 755,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-24-034986 · tm248811-1_4seq1.xml · derivative · entry 2 Nantahala Capital Management, LLC · CIK 0001472322 · 10% owner · See remarks Harkey Wilmot B. · CIK 0001775952 · 10% owner · See remarks Mack Daniel · CIK 0001775831 · 10% owner · See remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 755,000 shares Expires 2024-03-15 F1 · ownership.nature: Nantahala Capital Management, LLC ("NCM"), an investment adviser to certain private funds and managed accounts (the "NCM Investors") that hold shares of Common Stock and held certain derivative securities related thereto (the "Derivatives"), including the put options disclosed in this Form 4, may be deemed or have been deemed a beneficial owner of such securities. Each of Mr. Wilmot B. Harkey and Mr. Daniel Mack may be deemed a beneficial owner of the securities beneficially owned by NCM. Each of NCM, Mr. Harkey and Mr. Mack (the "Reporting Persons") disclaims beneficial ownership of the securities disclosed herein except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 16:01 UTC |
Nantahala Capital Management, LLC10% owner · See remarks
Harkey Wilmot B.10% owner · See remarks
Mack Daniel10% owner · See remarks
|
OtherCommon Stock | 755,000 | $5.00 | $3,775,000.00 |
DisclosureSEC source: 0001104659-24-034986 · tm248811-1_4seq1.xml · nonDerivative · entry 1 Nantahala Capital Management, LLC · CIK 0001472322 · 10% owner · See remarks Harkey Wilmot B. · CIK 0001775952 · 10% owner · See remarks Mack Daniel · CIK 0001775831 · 10% owner · See remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,992,519 F1 · ownership.nature: Nantahala Capital Management, LLC ("NCM"), an investment adviser to certain private funds and managed accounts (the "NCM Investors") that hold shares of Common Stock and held certain derivative securities related thereto (the "Derivatives"), including the put options disclosed in this Form 4, may be deemed or have been deemed a beneficial owner of such securities. Each of Mr. Wilmot B. Harkey and Mr. Daniel Mack may be deemed a beneficial owner of the securities beneficially owned by NCM. Each of NCM, Mr. Harkey and Mr. Mack (the "Reporting Persons") disclaims beneficial ownership of the securities disclosed herein except to the extent of their respective pecuniary interests therein. Read SEC document |
| March 12, 2024 Filed Mar 12, 2024 22:39 UTC |
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 8,000 | $1.12 | $8,995.20 |
DisclosureSEC source: 0001415889-24-007710 · form4-03122024_100323.xml · nonDerivative · entry 2 Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,806 F1 · price: The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $1.105 to $1.1683 on March 12, 2024. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 22:39 UTC |
Angotti Vincent J.Director · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 1,000 | $1.12 | $1,115.00 |
DisclosureSEC source: 0001415889-24-007710 · form4-03122024_100323.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,806 Read SEC document |
| March 03, 2024 Filed Mar 5, 2024 01:57 UTC |
Dasu Badri NChief Engineering Officer
|
Tax withholdingCommon Stock | 406 | $1.30 | $527.80 |
DisclosureSEC source: 0001209191-24-004246 · doc4.xml · nonDerivative · entry 1 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,414 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| March 03, 2024 Filed Mar 5, 2024 01:55 UTC |
Palmer Pamela PChief Medical Officer
|
Tax withholdingCommon Stock | 450 | $1.30 | $585.00 |
DisclosureSEC source: 0001209191-24-004245 · doc4.xml · nonDerivative · entry 1 Palmer Pamela P · CIK 0001511365 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,149 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Balance includes non-reportable acquisition of 6,255 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| March 03, 2024 Filed Mar 5, 2024 01:54 UTC |
ASADORIAN RAFFIChief Financial Officer
|
Tax withholdingCommon Stock | 558 | $1.30 | $725.40 |
DisclosureSEC source: 0001209191-24-004244 · doc4.xml · nonDerivative · entry 1 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,733 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| March 03, 2024 Filed Mar 5, 2024 01:53 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
Tax withholdingCommon Stock | 1,623 | $1.30 | $2,109.90 |
DisclosureSEC source: 0001209191-24-004243 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,806 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Balance includes non-reportable acquisition of 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| February 14, 2024 Filed Feb 28, 2024 02:06 UTC |
Palmer Pamela PDirector · Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 108,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001209191-24-004045 · doc4.xml · derivative · entry 2 Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,000 Underlying: Common Stock · 108,000 shares Expires 2034-02-13 F2 · derivative.exercise_date: On February 14, 2024, the reporting person was granted an option to purchase 108,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.